Statistic data also showed that compared with KLRG1−CD8 T cells, which did not display obvious cytotoxicity against tumor cells, KLRG1+CD8 T cells killed B16 cells (Fig. 5b) and EL4 cells (Fig. 5c) with much higher killing rates. This evidence concerns the gene KLRG1 and neoplasm.